X-54809928-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_177433.3(MAGED2):āc.252A>Gā(p.Ser84=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.352 in 1,196,048 control chromosomes in the GnomAD database, including 51,377 homozygotes. There are 137,072 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.34 ( 4686 hom., 10959 hem., cov: 21)
Exomes š: 0.35 ( 46691 hom. 126113 hem. )
Consequence
MAGED2
NM_177433.3 synonymous
NM_177433.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.10
Genes affected
MAGED2 (HGNC:16353): (MAGE family member D2) This gene is a member of the MAGED gene family. The MAGED genes are clustered on chromosome Xp11. This gene is located in Xp11.2, a hot spot for X-linked intellectual disability (XLID). Mutations in this gene cause a form of transient antenatal Bartter's syndrome. This gene may also be involved in several types of cancer, including breast cancer and melanoma. The protein encoded by this gene is progressively recruited from the cytoplasm to the nucleoplasm during the interphase and after nucleolar stress and is thus thought to play a role in cell cycle regulation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant X-54809928-A-G is Benign according to our data. Variant chrX-54809928-A-G is described in ClinVar as [Benign]. Clinvar id is 1244776.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-54809928-A-G is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=1.1 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.595 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAGED2 | NM_177433.3 | c.252A>G | p.Ser84= | synonymous_variant | 3/13 | ENST00000375068.6 | NP_803182.1 | |
MAGED2 | NM_014599.6 | c.252A>G | p.Ser84= | synonymous_variant | 3/13 | NP_055414.2 | ||
MAGED2 | NM_201222.3 | c.252A>G | p.Ser84= | synonymous_variant | 3/13 | NP_957516.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAGED2 | ENST00000375068.6 | c.252A>G | p.Ser84= | synonymous_variant | 3/13 | 1 | NM_177433.3 | ENSP00000364209 | P1 |
Frequencies
GnomAD3 genomes AF: 0.341 AC: 37391AN: 109663Hom.: 4698 Cov.: 21 AF XY: 0.342 AC XY: 10935AN XY: 31957
GnomAD3 genomes
AF:
AC:
37391
AN:
109663
Hom.:
Cov.:
21
AF XY:
AC XY:
10935
AN XY:
31957
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.367 AC: 57632AN: 157094Hom.: 7775 AF XY: 0.361 AC XY: 17544AN XY: 48626
GnomAD3 exomes
AF:
AC:
57632
AN:
157094
Hom.:
AF XY:
AC XY:
17544
AN XY:
48626
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.353 AC: 383735AN: 1086329Hom.: 46691 Cov.: 34 AF XY: 0.355 AC XY: 126113AN XY: 355205
GnomAD4 exome
AF:
AC:
383735
AN:
1086329
Hom.:
Cov.:
34
AF XY:
AC XY:
126113
AN XY:
355205
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.341 AC: 37388AN: 109719Hom.: 4686 Cov.: 21 AF XY: 0.342 AC XY: 10959AN XY: 32023
GnomAD4 genome
AF:
AC:
37388
AN:
109719
Hom.:
Cov.:
21
AF XY:
AC XY:
10959
AN XY:
32023
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 08, 2018 | - - |
Bartter disease type 5 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at